Longeveron Files Form D for Exempt Securities Offering
Ticker: LGVN · Form: D · Filed: Mar 25, 2026 · CIK: 0001721484
Complexity: simple
Sentiment: neutral
Topics: exempt-offering, capital-raise, form-d
TL;DR
**Longeveron is raising money through a private offering, watch for details on dilution.**
AI Summary
Longeveron Inc. filed a Form D on March 25, 2026, indicating a notice of an exempt offering of securities. This filing, under the Securities Act of 1933, suggests Longeveron is raising capital without a full SEC registration, likely through a private placement. For investors, this means the company is seeking funding, which could be for R&D, operations, or expansion, and understanding the terms of this offering (not detailed here) is crucial as it could dilute existing shares or impact future profitability.
Why It Matters
This filing signals Longeveron Inc. is raising capital, which could fund growth but also potentially dilute existing shareholders if new shares are issued.
Risk Assessment
Risk Level: medium — While raising capital can be positive, the lack of specific details on the offering terms in this Form D introduces uncertainty regarding potential dilution or the cost of capital.
Analyst Insight
Investors should monitor Longeveron Inc. for subsequent filings or press releases that provide specific details about the terms, size, and use of proceeds for this exempt offering to assess potential dilution and impact on future growth.
Key Players & Entities
- Longeveron Inc. (company) — the filer of the Form D
- 0001721484 (company) — Longeveron Inc.'s CIK number
- 2026-03-25 (date) — the filing and acceptance date of the Form D
FAQ
What type of filing did Longeveron Inc. submit?
Longeveron Inc. submitted a Form D, which is a 'Notice of Exempt Offering of Securities' as indicated by the SEC Accession No. 0001721484-26-000001.
When was this Form D filed and accepted by the SEC?
The Form D was filed and accepted on March 25, 2026, according to the filing details.
What is Longeveron Inc.'s CIK number?
Longeveron Inc.'s CIK number is 0001721484, as stated in the filing details.
What is Longeveron Inc.'s primary SIC code and what does it represent?
Longeveron Inc.'s primary SIC code is 2834, which represents 'Pharmaceutical Preparations'.
What is the business address listed for Longeveron Inc. in this filing?
The business address listed for Longeveron Inc. is 1951 NW 7TH AVENUE SUITE 520, MIAMI FL 33136.
Filing Stats: 1,765 words · 7 min read · ~6 pages · Grade level 17.2 · Accepted 2026-03-25 10:13:59
Key Financial Figures
- $1 — enues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,
- $1,000,000 — No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,
- $5,000,000 — Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001
- $1,000,001 — e $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000
- $5,000,001 — $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
- $25,000,000 — $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001
- $25,000,001 — $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
- $50,000,000 — 5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,0
- $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $1
- $50,000,001 — 0,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 O
- $1,112,300.01 — itial closing, placement agent received $1,112,300.01 & warrants to purchase up to 2,019,231
- $0.65 — 1 shares of Common Stock exercisable at $0.65 per share, among other items. Contingen
Filing Documents
- primary_doc.html (D)
- primary_doc.xml (D) — 18KB
- 0001721484-26-000001.txt ( ) — 19KB
From the Filing
Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type LONGEVERON LLC Corporation Limited Partnership Limited Liability Company General Partnership Business Trust Other Name of Issuer Longeveron Inc. Jurisdiction of Incorporation/Organization DELAWARE Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) Yet to Be Formed 2. Principal Place of Business and Contact Information Name of Issuer Longeveron Inc. Street Address 1 Street Address 2 1951 NW 7TH AVENUE SUITE 520 MIAMI FLORIDA 33136 305-909-0840 3. Related Persons Last Name First Name Middle Name Willard Stephen H. Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Hare Joshua M. Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Locklear Lisa A. Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Agafonova Nataliya Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Lehr Paul Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Blass Devin Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Soffer Rock Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Ungaro Ursula Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Hajjar Roger Joseph Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Paletta, Jr. George Street Address 1 Street Address 2 1951 NW 7th Avenue Suite 520 Miami FLORIDA 33136 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) 4. Industry Group Agriculture Banking & Financial Services Commercial Banking Insurance Investing Investment Banking Pooled Investment Fund Other Banking & Financial Services Business Services Energy Coal Mining Electric Utilities Energy Conservation Environmental Services Oil & Gas Other Energy Health Care Biotechnology Health Insurance Hospitals & Physicians Pharmaceuticals Other Health Care Manufacturing Real Estate Commercial Construction REITS & Finance Residential Other Real Estate Retailing Restaurants Technology Computers Telecommunications Other Technology Travel Airlines & Airports Lodging & Conventions Tourism & Travel Services Other Travel Other 5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 Over $100,000,000 Decline to Disclose Decline to Disclose Not Applicable Not Applicable 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b) Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3